© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
November 17, 2017
A recent study, the first of its kind, reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are interesting gender differences.
September 01, 2015
Can tofoglifozin overcome patient adverse events to join the SGLT2 inhibitor market?
July 29, 2015
This quiz will help you better assess whether or not to prescribe an SGLT2 inhibitor for your type 2 diabetes patients.
July 02, 2015
The Food and Drug Administration (FDA) issued a formal communication warning about the risk of acidosis with the use of SGLT2 inhibitors.